Viramal Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

Viramal General Information

Description

Developer of biological therapies designed to improve the quality of women's health worldwide. The company's therapies provide treatments for fertility, menopausal hormone therapy, contraception, vaginal dryness, and other sexual conditions with optimal safety, efficacy, and patient acceptability, with fewer side effects, enabling women to take care of sensitive female reproductive areas with safety.

Contact Information

Website
www.viramal.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 167-169 Great Portland Street
  • London W1W 5PF
  • England, United Kingdom
+44 020
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
FemTech, Life Sciences
Corporate Office
  • 167-169 Great Portland Street
  • London W1W 5PF
  • England, United Kingdom
+44 020

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Viramal Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 01-Oct-2022 Completed Generating Revenue
4. Later Stage VC (Series B) Cancelled Generating Revenue
3. Later Stage VC (Series A) 03-Sep-2019 Completed Generating Revenue
2. Early Stage VC 01-Apr-2016 $4.81M $5.93M Completed Generating Revenue
1. Angel (individual) 19-May-2014 $1.12M $1.12M Completed Generating Revenue
To view Viramal’s complete valuation and funding history, request access »

Viramal Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 201,560 $0.012155 $1.52 $1.52 1x $1.52 7.04%
Ordinary 126,686 $0.012155 $1.06 $1.06 1x $1.06 4.43%
To view Viramal’s complete cap table history, request access »

Viramal Patents

  • 69

    Total Documents Applications and Grants

  • Total Patents Families

  • 44

    Granted

  • 16

    Pending

  • Expiring in next 12 mo

Viramal Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4658370-A1 Compositions for peritoneal drug delivery and methods of use thereof Pending 30-Jan-2023
US-20250352557-A1 Compositions for peritoneal drug delivery and methods of use thereof Pending 30-Jan-2023
WO-2024163513-A1 Compositions for peritoneal drug delivery and methods of use thereof Inactive 30-Jan-2023
WO-2024163513-A9 Compositions for peritoneal drug delivery and methods of use thereof Inactive 30-Jan-2023
AU-2021290181-A1 A hydroalcoholic gel and a method of manufacturing said gel Active 11-Jun-2020 A61K8/34
To view Viramal’s complete patent history, request access »

Viramal Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Viramal Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Medeon Science Park Accelerator/Incubator
NCL Technology Ventures Venture Capital Minority
To view Viramal’s complete investors history, request access »

Viramal Investments (1)

Viramal’s most recent deal was a Corporate Asset Purchase with Aptys Pharmaceuticals (TestoCream License). The deal was made on 01-Mar-2015.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Aptys Pharmaceuticals (TestoCream License) 01-Mar-2015 Corporate Asset Purchase Buildings and Property
To view Viramal’s complete investments history, request access »

Ready to get started?

Request a free trial

Viramal FAQs

  • When was Viramal founded?

    Viramal was founded in 2013.

  • Where is Viramal headquartered?

    Viramal is headquartered in London, United Kingdom.

  • What is the size of Viramal?

    Viramal has 15 total employees.

  • What industry is Viramal in?

    Viramal’s primary industry is Drug Discovery.

  • Is Viramal a private or public company?

    Viramal is a Private company.

  • What is Viramal’s current revenue?

    The current revenue for Viramal is .

  • How much funding has Viramal raised over time?

    Viramal has raised $8.52M.

  • Who are Viramal’s investors?

    Medeon Science Park and NCL Technology Ventures have invested in Viramal.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process